- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Locally Advanced (Inoperable) or Metastatic Breast Cancer in United Kingdom
Total 1751 results
-
Novartis PharmaceuticalsCompletedMetastatic Breast CancerUnited States, Canada, Finland, France, Italy, Spain, Taiwan, United Kingdom
-
Ikena OncologyBristol-Myers SquibbCompletedNeoplasms | Neoplasm Metastasis | Solid Tumor | Metastatic Cancer | Bladder Cancer | Advanced Solid Tumor | Advanced Cancer | Urothelial Carcinoma Bladder | Urothelial Carcinoma | Metastatic Urothelial Carcinoma | Solid Tumor, Adult | Bladder Disease | Solid Carcinoma | Neoplasm Malignant | Neoplasm, Bladder | Locally Advanced... and other conditionsUnited States
-
National Cancer Institute (NCI)RecruitingAdvanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Unresectable Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Triple-Negative Breast CarcinomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedMetastatic Skin Squamous Cell Carcinoma | Metastatic Malignant Neoplasm | Unresectable Malignant Neoplasm | Refractory Malignant Neoplasm | Appendix Adenocarcinoma | Locally Advanced Malignant Neoplasm | Skin Squamous Cell Carcinoma | Locally Advanced Skin Squamous Cell Carcinoma | Metastatic Small... and other conditionsUnited States
-
Leap Therapeutics, Inc.Pfizer; Merck KGaA, Darmstadt, GermanyTerminatedSolid Tumors | Advanced Triple Negative Breast Cancer | Advanced Hormone Receptor Positive/Endocrine Refractory Breast Cancer | Advanced Metastatic Castration-Resistant Prostate Cancer | Advanced Platinum-Resistant Ovarian CancerUnited States
-
Merck Sharp & Dohme LLCRecruitingAdvanced or Metastatic Solid TumorsUnited States, Canada, Israel, Netherlands
-
Saint Luke's Health SystemNovartis PharmaceuticalsRecruitingMetastatic Breast Cancer | HER2-negative Breast CancerUnited States
-
Piramal Enterprises LimitedMelanoma Research Foundation Breakthrough ConsortiumSuspendedAdvanced or Inoperable Malignant Melanoma With BRAF MutationUnited States
-
Daehwa Pharmaceutical Co., Ltd.CompletedRecurrent or Metastatic Breast CancerUnited States, Czechia
-
Rahul AggarwalAstraZenecaRecruitingClear Cell Renal Cell Carcinoma | Metastatic Renal Cell Carcinoma | Endometrial Cancer | Stage III Renal Cell Cancer | Locally Advanced Malignant Solid Neoplasm | Stage III Pancreatic Cancer | Stage IV Pancreatic Cancer | Metastatic Malignant Solid Neoplasm | Metastatic Urothelial Carcinoma | Stage IV... and other conditionsUnited States
-
Adrienne G. WaksGilead SciencesRecruitingBreast Cancer Female | Breast Cancer Metastatic | Her 2 Positive Breast CancerUnited States
-
Incyte CorporationNovartis PharmaceuticalsCompletedSolid Tumor | Metastatic Cancer | Advanced CancerUnited States
-
NBE-Therapeutics AGCmed Clinical ServicesTerminatedTriple Negative Breast Cancer | Advanced Solid Tumor | Advanced CancerUnited States
-
University of California, IrvineRecruitingBreast Cancer | Metastatic Breast Cancer | HER2-negative Breast Cancer | Hormone Receptor-positive Breast CancerUnited States
-
Janssen Diagnostics, LLCCompletedMetastatic Breast CancerUnited States, Canada
-
University of Michigan Rogel Cancer CenterCompletedGenetic Risk of Osteonecrosis of the Jaw (ONJ) in Patients With Metastatic Cancer: Concordance StudyBreast CancerUnited States
-
Fox Chase Cancer CenterIncuronSuspendedLocally Advanced or Metastatic MelanomaUnited States
-
AmgenRoche-GenentechCompletedMetastatic Colorectal Cancer | Metastatic Triple Negative Breast CancerUnited States, Belgium, Spain, Australia, Switzerland, Germany
-
M.D. Anderson Cancer CenterRecruitingMalignant Solid Neoplasm | Metastatic Renal Cell Carcinoma | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC v8 | Prognostic Stage III Breast Cancer AJCC v8 | Prognostic Stage... and other conditionsUnited States
-
University of LouisvilleJames Graham Brown Cancer CenterRecruitingMetastatic Breast CancerUnited States
-
Minerva Biotechnologies CorporationCity of Hope Medical CenterRecruitingMetastatic Breast CancerUnited States
-
Rush University Medical CenterTerminatedMetastatic Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterMedImmune LLCCompletedMetastatic Breast CancerUnited States
-
University of Maryland, BaltimoreGenentech, Inc.TerminatedMetastatic Breast CancerUnited States
-
Abramson Cancer Center of the University of PennsylvaniaTerminatedMETASTATIC BREAST CANCERUnited States
-
Baylor Research InstituteCompletedMetastatic Breast CancerUnited States
-
University of Wisconsin, MadisonNational Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.TerminatedMetastatic Breast CancerUnited States
-
University of Alabama at BirminghamGenentech, Inc.CompletedMetastatic Breast CancerUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompleted
-
Milton S. Hershey Medical CenterAvon FoundationCompletedMetastatic Breast CancerUnited States
-
Weill Medical College of Cornell UniversityBristol-Myers SquibbCompletedMetastatic Breast CancerUnited States
-
Western Regional Medical CenterTerminated
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; AstraZeneca; Brigham and Women's HospitalCompletedMetastatic Breast CancerUnited States
-
M.D. Anderson Cancer CenterCTI BioPharmaCompletedBreast Cancer | Metastatic Breast CancerUnited States
-
AgennixCompleted
-
Cancer Research NetworkHoffmann-La RocheCompletedMetastatic Breast CancerUnited States
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Brigham and Women's HospitalCompletedBreast Cancer | Metastatic Breast CancerUnited States
-
Columbia UniversityNational Cancer Institute (NCI); Acetylon Pharmaceuticals IncorporatedCompletedMetastatic Breast Cancer | Breast CarcinomaUnited States
-
Rainier TherapeuticsTerminatedUrinary Bladder Disease | Locally Advanced or Metastatic Urothelial Cell Carcinoma | Urological DiseasesUnited States, Spain, Belgium, France, Germany, Italy, Korea, Republic of, Turkey, Hungary, Netherlands, Serbia, Poland, Russian Federation, Sweden, Moldova, Republic of, Denmark, Ukraine
-
R-PharmCompletedMetastatic Breast CancerItaly, United Kingdom, United States, France, Spain
-
Memorial Sloan Kettering Cancer CenterContext Therapeutics Inc.WithdrawnMetastatic Breast Cancer | Unresectable Breast CancerUnited States
-
Yale UniversityFoundation MedicineCompleted
-
Dartmouth-Hitchcock Medical CenterTerminated
-
University of Michigan Rogel Cancer CenterAventis Pharmaceuticals; Rhone-Poulenc RorerCompletedMetastatic Breast CancerUnited States
-
Dartmouth-Hitchcock Medical CenterHoffmann-La RocheCompletedMetastatic Breast CancerUnited States
-
University of Michigan Rogel Cancer CenterTerminated
-
Genzyme, a Sanofi CompanyWorldwide Clinical TrialsCompletedSymptomatic, Aggressive, Sporadic, Unresectable, Locally | Advanced/Metastatic Medullary Thyroid Cancer (MTC)Belgium, Italy, Netherlands, Spain, France, Germany, United Kingdom, Luxembourg
-
OSI PharmaceuticalsCompletedLocally Recurrent or Metastatic Cancer of the Head and Neck | Must Have Failed First-Line TherapyUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingBreast Cancer | Metastatic Breast Cancer | ER+ Breast Cancer | Metastatic Breast Carcinoma | HER2+ Breast Cancer | Oligometastatic Breast CarcinomaUnited States
-
Washington University School of MedicineBiovicaNot yet recruitingMetastatic Breast Cancer | Unresectable Breast CancerUnited States